Plasma catechols and monoamine oxidase metabolites in untreated Parkinson's and Alzheimer's diseases
Identifieur interne : 001474 ( Main/Curation ); précédent : 001473; suivant : 001475Plasma catechols and monoamine oxidase metabolites in untreated Parkinson's and Alzheimer's diseases
Auteurs : J. Eric Ahlskog [États-Unis] ; Ryan J. Uitti [États-Unis] ; Gertrude M. Tyce [États-Unis] ; John F. O'Brien [États-Unis] ; Ronald C. Petersen [États-Unis] ; Emre Kokmen [États-Unis]Source :
- Journal of the Neurological Sciences [ 0022-510X ] ; 1995.
Abstract
Prior studies have documented functional and pathological compromise of the peripheral sympathetic nervous system in patients with Parkinson's disease, suggesting the possibility of reduced catecholamine release into the circulation. We measured free plasma catechols in early and untreated patients with Parkinson's disease, but found no evidence of reduced concentrations, compared to control subjects or a group of patients with probable Alzheimer's disease. Rather, there was a significant elevation of plasma norepinephrine within the Parkinson's disease group. Furthermore, 6 of 15 untreated Parkinson's disease patients (40%) displayed markedly elevated plasma concentrations of the catecholamine MAO metabolites, DOPAC or DOPEG. Despite this finding, platelet MAO-B activity measured in these and all other Parkinson's disease patients fell well within the range of the control subjects, and was also statistically similar to the group with Alzheimer's type dementia. Plasma dopa levels were similar in all groups, whereas the majority of patients in the three groups had plasma free dopamine and epinephrine concentrations below the limits of detection. These trends toward increased, rather than decreased, circulating catechol concentrations suggest that peripheral sympathetic nervous system catecholamine production and release is not severely compromised in patients with early Parkinson's disease. In addition, we were unable to confirm certain previous reports of elevated MAO-B activity in patients with Parkinson's or Alzheimer's diseases.
Url:
DOI: 10.1016/0022-510X(95)00318-V
Links toward previous steps (curation, corpus...)
- to stream Main, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001710
Links to Exploration step
ISTEX:F164C656FA89DA0907A2F1EBDEA8FAB39E920533Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Plasma catechols and monoamine oxidase metabolites in untreated Parkinson's and Alzheimer's diseases</title><author><name sortKey="Ahlskog, J Eric" sort="Ahlskog, J Eric" uniqKey="Ahlskog J" first="J. Eric" last="Ahlskog">J. Eric Ahlskog</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Mayo Clinic Rochester, Rochester, MI 55905, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Mayo Clinic Rochester, Rochester, MI 55905</wicri:regionArea></affiliation></author><author><name sortKey="Uitti, Ryan J" sort="Uitti, Ryan J" uniqKey="Uitti R" first="Ryan J." last="Uitti">Ryan J. Uitti</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Mayo Clinic Jacksonville; Jacksonville, FL, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Mayo Clinic Jacksonville; Jacksonville, FL</wicri:regionArea></affiliation></author><author><name sortKey="Tyce, Gertrude M" sort="Tyce, Gertrude M" uniqKey="Tyce G" first="Gertrude M." last="Tyce">Gertrude M. Tyce</name><affiliation wicri:level="1"><mods:affiliation>Department of Physiology and Biophysics, Mayo Clinic Rochester, Rochester, MN 55905, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Physiology and Biophysics, Mayo Clinic Rochester, Rochester, MN 55905</wicri:regionArea></affiliation></author><author><name sortKey="O Brien, John F" sort="O Brien, John F" uniqKey="O Brien J" first="John F." last="O'Brien">John F. O'Brien</name><affiliation wicri:level="1"><mods:affiliation>Department Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, MN 55905, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, MN 55905</wicri:regionArea></affiliation></author><author><name sortKey="Petersen, Ronald C" sort="Petersen, Ronald C" uniqKey="Petersen R" first="Ronald C." last="Petersen">Ronald C. Petersen</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Mayo Clinic Rochester, Rochester, MI 55905, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Mayo Clinic Rochester, Rochester, MI 55905</wicri:regionArea></affiliation></author><author><name sortKey="Kokmen, Emre" sort="Kokmen, Emre" uniqKey="Kokmen E" first="Emre" last="Kokmen">Emre Kokmen</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Mayo Clinic Rochester, Rochester, MI 55905, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Mayo Clinic Rochester, Rochester, MI 55905</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:F164C656FA89DA0907A2F1EBDEA8FAB39E920533</idno><date when="1996" year="1996">1996</date><idno type="doi">10.1016/0022-510X(95)00318-V</idno><idno type="url">https://api.istex.fr/document/F164C656FA89DA0907A2F1EBDEA8FAB39E920533/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">001710</idno><idno type="wicri:Area/Main/Curation">001474</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">Plasma catechols and monoamine oxidase metabolites in untreated Parkinson's and Alzheimer's diseases</title><author><name sortKey="Ahlskog, J Eric" sort="Ahlskog, J Eric" uniqKey="Ahlskog J" first="J. Eric" last="Ahlskog">J. Eric Ahlskog</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Mayo Clinic Rochester, Rochester, MI 55905, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Mayo Clinic Rochester, Rochester, MI 55905</wicri:regionArea></affiliation></author><author><name sortKey="Uitti, Ryan J" sort="Uitti, Ryan J" uniqKey="Uitti R" first="Ryan J." last="Uitti">Ryan J. Uitti</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Mayo Clinic Jacksonville; Jacksonville, FL, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Mayo Clinic Jacksonville; Jacksonville, FL</wicri:regionArea></affiliation></author><author><name sortKey="Tyce, Gertrude M" sort="Tyce, Gertrude M" uniqKey="Tyce G" first="Gertrude M." last="Tyce">Gertrude M. Tyce</name><affiliation wicri:level="1"><mods:affiliation>Department of Physiology and Biophysics, Mayo Clinic Rochester, Rochester, MN 55905, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Physiology and Biophysics, Mayo Clinic Rochester, Rochester, MN 55905</wicri:regionArea></affiliation></author><author><name sortKey="O Brien, John F" sort="O Brien, John F" uniqKey="O Brien J" first="John F." last="O'Brien">John F. O'Brien</name><affiliation wicri:level="1"><mods:affiliation>Department Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, MN 55905, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, MN 55905</wicri:regionArea></affiliation></author><author><name sortKey="Petersen, Ronald C" sort="Petersen, Ronald C" uniqKey="Petersen R" first="Ronald C." last="Petersen">Ronald C. Petersen</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Mayo Clinic Rochester, Rochester, MI 55905, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Mayo Clinic Rochester, Rochester, MI 55905</wicri:regionArea></affiliation></author><author><name sortKey="Kokmen, Emre" sort="Kokmen, Emre" uniqKey="Kokmen E" first="Emre" last="Kokmen">Emre Kokmen</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Mayo Clinic Rochester, Rochester, MI 55905, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Mayo Clinic Rochester, Rochester, MI 55905</wicri:regionArea></affiliation></author></analytic><monogr></monogr><series><title level="j">Journal of the Neurological Sciences</title><title level="j" type="abbrev">JNS</title><idno type="ISSN">0022-510X</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1995">1995</date><biblScope unit="volume">136</biblScope><biblScope unit="issue">1–2</biblScope><biblScope unit="page" from="162">162</biblScope><biblScope unit="page" to="168">168</biblScope></imprint><idno type="ISSN">0022-510X</idno></series><idno type="istex">F164C656FA89DA0907A2F1EBDEA8FAB39E920533</idno><idno type="DOI">10.1016/0022-510X(95)00318-V</idno><idno type="PII">0022-510X(95)00318-V</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0022-510X</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Prior studies have documented functional and pathological compromise of the peripheral sympathetic nervous system in patients with Parkinson's disease, suggesting the possibility of reduced catecholamine release into the circulation. We measured free plasma catechols in early and untreated patients with Parkinson's disease, but found no evidence of reduced concentrations, compared to control subjects or a group of patients with probable Alzheimer's disease. Rather, there was a significant elevation of plasma norepinephrine within the Parkinson's disease group. Furthermore, 6 of 15 untreated Parkinson's disease patients (40%) displayed markedly elevated plasma concentrations of the catecholamine MAO metabolites, DOPAC or DOPEG. Despite this finding, platelet MAO-B activity measured in these and all other Parkinson's disease patients fell well within the range of the control subjects, and was also statistically similar to the group with Alzheimer's type dementia. Plasma dopa levels were similar in all groups, whereas the majority of patients in the three groups had plasma free dopamine and epinephrine concentrations below the limits of detection. These trends toward increased, rather than decreased, circulating catechol concentrations suggest that peripheral sympathetic nervous system catecholamine production and release is not severely compromised in patients with early Parkinson's disease. In addition, we were unable to confirm certain previous reports of elevated MAO-B activity in patients with Parkinson's or Alzheimer's diseases.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001474 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 001474 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Curation
|type= RBID
|clé= ISTEX:F164C656FA89DA0907A2F1EBDEA8FAB39E920533
|texte= Plasma catechols and monoamine oxidase metabolites in untreated Parkinson's and Alzheimer's diseases
}}
| This area was generated with Dilib version V0.6.23. |  |